Cite
HARVARD Citation
Ueda, K. et al. (2022). Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab. Japanese journal of clinical oncology. pp. 179-186. [Online].